Skip to Content for (none) Menu for (none) About Us Menu Research Menu Development Menu Medicines Menu Investors Menu Media Menu Careers Menu
Banner Image
July Thursday, Jul 02, 2009
Phase III Study Showed Lucentis Improved Vision in Patients with Branch Retinal Vein Occlusion

May Saturday, May 30, 2009
Genentech Announces Full Results from First Phase III Study of Avastin in Early-Stage Colon Cancer

Saturday, May 30, 2009
Phase III Study Showed Patients Lived Longer Without Advanced Lung Cancer Progressing When Tarceva Was Added to Avastin as First-Line Maintenance Therapy

Friday, May 29, 2009
Avastin Plus Commonly Used Chemotherapies Improved Progression-Free Survival in Advanced Breast Cancer

Tuesday, May 19, 2009
Genentech and Biogen Idec Submit Applications to the FDA for Rituxan for Most Common Type of Adult Leukemia

Thursday, May 14, 2009
Genentech to Present Advances With Targeted Cancer Medicines at ASCO

Tuesday, May 05, 2009
FDA Grants Accelerated Approval of Avastin for Brain Cancer (Glioblastoma) That Has Progressed Following Prior Therapy

April Tuesday, Apr 21, 2009
Phase III C-08 Study of Avastin in Early-Stage Colon Cancer Did Not Meet Primary Endpoint

Wednesday, Apr 08, 2009
Genentech Announces Voluntary Withdrawal of Raptiva from the U.S. Market

See the Archives See the Archives
 
Search Releases

Begin Date:


End Date:


Category:
Keyword: